WATERTOWN, Mass. (AP) — WATERTOWN, Mass. (AP) — Enanta Pharmaceuticals Inc. (ENTA) on Wednesday reported a loss of $33.4 million in its fiscal first quarter.

On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of $1.58.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.18 per share.

The biotechnology company posted revenue of $18 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $22.7 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENTA at https://www.zacks.com/ap/ENTA

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News